According to the study, semaglutide appears to be an effective medicine for treating obesity
The risk of type 2 diabetes (T2D) is more than halved with weekly injections of the new obesity drug semaglutide, according to new research being presented at the annual meeting of the European Association for the Study of of Diabetes (EASD) in Stockholm, Sweden (19). -September 23). Semaglutide was recently approved in the US to …